Neonatal Respiratory Disorder
Neonatal respiratory distress syndrome (RDS) affects approximately 40,000 infants each year in the United States. Although the mortality rate has decreased dramatically over past decades, many infants still perish or have chronic conditions that are associated with the treatment of the syndrome (i.e., oxygen and positive pressure).
RDS is a disease of prematurity. The incidence increases with decreasing gestational age, occurring in more than 80% in neonates less than 28 weeks. The major factors in the pathophysiology of RDS include surfactant deficiency, underdeveloped alveolar units and capillaries and decreased alveolar surface area, reduced lung compliance, poor gas exchange, and the presence of a ductus arteriosus.
Pathophysiology
Clinical Manifestations
Treatment
Bubble CPAP
According to research Iran J Pediatr. 2011 Jun; 21(2): 151–158.